Frontage launches $205m Hong Kong spin-off

Chinese drug services provider Frontage Holdings Corp has kicked off bookbuilding for its IPO, vying for proceeds of up to HK$1.60bn ($204.6m).

  • By Jonathan Breen
  • 15 May 2019

The firm, being spun-off by China’s Tigermed Group, is looking to float 501.9m primary shares and has put up a 15% greenshoe of 75.3m new shares, according to a term sheet seen by GlobalCapital Asia.

Joint sponsors Bank of America and Goldman Sachs, working alongside global co-ordinators CLSA ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Panda Bonds Top Arrangers

Rank Arranger Share % by Volume
1 Bank of China (BOC) 21.85
2 China Merchants Securities Co 14.67
3 Industrial and Commercial Bank of China (ICBC) 14.44
4 Agricultural Bank of China (ABC) 8.89
5 China Securities 7.41

Bookrunners of Asia-Pac (ex-Japan) ECM

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 CITIC Securities 9,346.38 46 7.94%
2 Goldman Sachs 8,791.68 35 7.47%
3 Morgan Stanley 6,937.95 46 5.90%
4 China International Capital Corp Ltd 6,923.83 42 5.89%
5 UBS 6,281.96 46 5.34%

Bookrunners of Asia Pacific (ex-Japan) G3 DCM

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 HSBC 20,431.60 178 8.34%
2 Citi 15,045.64 113 6.14%
3 JPMorgan 12,957.39 88 5.29%
4 Standard Chartered Bank 10,012.82 100 4.09%
5 Bank of China 9,332.67 116 3.81%

Asian polls & awards